Back |
home / stock / arct / arct message board
Subject | By | Source | When |
---|---|---|---|
whytestocks: $ARCT News Article - Arcturus Therapeutics to Participate in Two Panels at the ROTH RNA | whytestocks | investorshangout | 07/10/2019 5:45:40 PM |
whytestocks: $ARCT News Article - Ultragenyx and Arcturus Therapeutics Expand Existing Research Coll | whytestocks | investorshangout | 06/19/2019 2:30:46 PM |
whytestocks: $ARCT News Article - Arcturus Therapeutics Announces Redomiciliation to the United Stat | whytestocks | investorshangout | 06/13/2019 6:50:41 PM |
whytestocks: $ARCT News Article - Arcturus Therapeutics Provides Corporate Update and Reports Fourth | whytestocks | investorshangout | 03/18/2019 7:00:39 PM |
News, Short Squeeze, Breakout and More Instantly...
Arcturus Therapeutics Ltd. Company Name:
ARCT Stock Symbol:
NASDAQ Market:
Arcturus Therapeutics Ltd. Website:
Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a global messenger RNA medicines company focused on the development of infectious disease vaccines and medicines to treat unmet medical needs within liver and respiratory rare diseases, toda...
2024-07-02 10:15:03 ET Piper Sandler analyst issues OVERWEIGHT recommendation for ARCT on July 2, 2024 08:19AM ET. The previous analyst recommendation was Overweight. ARCT was trading at $23.66 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...
ARCT-810 Phase 2 study completed enrollment at 0.3 mg/kg dose level in Europe with data expected later this year ARCT-810 to expand Phase 2 clinical program in the U.S. to enroll patients with more severe disease ARCT-032 IND for Phase 2 multiple ascending dose study to be submitt...